The pros and cons of buying Challenger shares this month

Could this be the right time to look at the annuity king?

| More on:
Two people comparing and analysing material.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Challenger Ltd (ASX: CGF) share price jumped 6.5% yesterday after reporting its FY24 result. Investors loved the ASX financial share's report which showed good growth. After such good numbers, it's worth asking if the annuity provider is a buy.

A business can still be good value even if it goes up in price because the reported numbers may have demonstrated that the current share price still doesn't reflect how good the outlook truly is.

The business reported a number of positives, which may bode well for FY25 (and beyond).

Let's run through some of the highlights before considering if it's a buy.

Positive result recap

The company reported that it generated normalised net profit before tax (NPBT) of $608 million, up 17%.

Challenger's group assets under management (AUM) grew by 21% to $127 billion, partly thanks to life sales of $9.1 billion, with lifetime annuity sales of $1.5 billion (up 110%).

Normalised earnings per share (EPS) grew by 14% to 60.9 cents per share. The normalised return on equity (ROE) was 15.6%, up 290 basis points (2.90%) – Challenger said it's on track to achieve its ROE target in FY25. The ROE target is the RBA cash rate plus a margin of 12%.

The board of Challenger decided to lift the full-year dividend by 10% to 26.5 cents per share.

However, the company did report that its statutory net profit after tax (NPAT) declined 24% to $130 million. This number included the unrealised impact of lower commercial property valuations and changes to the UK mortality rate assumptions.

The broker UBS said that earnings beat market expectations and were ahead of the guidance range, and the dividend was stronger than expected, which helped the Challenger share price rise. However, the statutory net profit was "surprisingly low due to very large investment experience loss". Despite that, the balance sheet strength improved.

UBS suggested there were some question marks on the company's capital position.  

Is the Challenger share price a buy?

The outlook for the business seems positive, in my opinion, though I'm wary that eventual lowering interest rates may make annuities seem a little less appealing to retirees if they lead to lower payment rates.

The broker believes the FY24 result "went a long way to addressing market concerns for life margins, capital and business quality". Cost control was a "key feature", and it sees "further earnings upside from this source".

UBS suggested that Challenger's guidance appears to be conservative, with the broker forecasting a net profit before tax of $695 million. Challenger's guidance for normalised NPBT is between $640 million and $700 million.

The broker rates Challenger shares as a buy and increased its price target to $8.30. That implies a possible rise of around 13% from today's level.

Challenger is guiding normalised net profit after tax will be between $440 million to $480 million. UBS is forecasting NPAT of $487 million in FY25 and $561 million in FY26.

The broker is also suggesting the annual dividend per share could rise to 31 cents per share in FY25 and 35 cents per share in FY26. The FY25 dividend could translate into a grossed-up dividend yield of around 6%.

Should you invest $1,000 in Macquarie Group Limited right now?

Before you buy Macquarie Group Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Macquarie Group Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Challenger. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Financial Shares

Ecstatic woman looking at her phone outside with her fist pumped.
Financial Shares

IAG share price charges higher on $1.35b deal and guidance update

This blue chip has made a big announcement. Here's what you need to know.

Read more »

A woman holds up hands to compare two things with question marks above her hands.
Financial Shares

Which is better value right now, Soul Patts or Brickworks shares?

Let's dive in and see what the experts have to say.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Financial Shares

How much upside does Macquarie tip for Pinnacle Investment Management shares?

Pinnacle could be a contender to continue rising, according to experts.

Read more »

Delighted adult man, working on a company slogan, on his laptop.
Financial Shares

Macquarie tips 28% upside for this ASX financial stock

This stock has a lot of potential.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Earnings Results

Why is the QBE share price racing ahead of the benchmark on Friday?

Investors are bidding up QBE shares today. But why?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Earnings Results

Macquarie share price leaps higher on rising full-year profits

Macquarie reported its full year FY 2025 results today. Here's why ASX investors are reacting enthusiastically.

Read more »

Woman and man calculating a dividend yield.
Financial Shares

Here's what Macquarie thinks QBE shares are worth after reviewing 18 global insurers

Macquarie has just issued a new note on QBE shares.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Financial Shares

Should I buy the dip on Macquarie shares now?

Atop their reliable passive income, Macquarie shares offer growth potential, according to this leading expert.

Read more »